41 results on '"Wells, Philip"'
Search Results
2. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis – A systematic review and meta-analysis
3. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study
4. Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer
5. Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis
6. Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study
7. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding
8. Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin
9. Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial
10. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study
11. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial
12. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study
13. Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores
14. Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials
15. Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: Systematic review and meta-analysis
16. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
17. Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis
18. Clinical Decision Rules and D-dimer in Venous Thromboembolism: Current controversies and future research priorities
19. Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
20. Effect of 200 μG/day of vitamin k1 on the variability of anticoagulation control in patients on warfarin: A randomized controlled trial
21. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement
22. Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?
23. Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trial
24. Psychological impact of thrombophilia testing in asymptomatic family members
25. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial
26. Media portrayals of pulmonary embolism
27. Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions
28. Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial
29. Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial
30. Efficacy of Low- molecular- weight- heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials
31. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients
32. Psychosocial aspects of venous thromboembolic disease: An exploratory study
33. The effect of hospitalization on oral anticoagulation control: A population-based study
34. Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: Safety and clinical utility of 4 methods to assign pre-test probability
35. Regarding the necessity of an updated meta-analysis on the prognostic value of serum biomarkers in patients with pulmonary embolism
36. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism
37. Management of direct oral anticoagulant associated bleeding: Results of a multinational survey
38. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy
39. N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study
40. Diagnosis of Pulmonary Embolism
41. Effect of 200μG/day of vitamin k1 on the variability of anticoagulation control in patients on warfarin: A randomized controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.